TREM2 is associated with advanced stages and inferior prognosis in oral squamous cell carcinoma
Triggering receptor expressed on myeloid cells 2 (TREM2) is suggested to hamper antitumor immune response in multiple cancers. However, the role of TREM2 in oral squamous cell carcinoma (OSCC) and its expression in tumor-associated macrophages (TAMs) are unknown. In this study, TREM2 expression was...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
24 September 2022
|
| In: |
Cancers
Year: 2022, Volume: 14, Issue: 19, Pages: 1-14 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers14194635 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14194635 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/19/4635 |
| Author Notes: | Ann-Kristin Struckmeier, Anne Radermacher, Michael Fehrenz, Dalia Alansary, Philipp Wartenberg, Mathias Wagner, Anja Scheller, Jochen Hess, Julius Moratin, Christian Freudlsperger, Jürgen Hoffmann, Lorenz Thurner, Klaus Roemer, Kolja Freier and Dominik Horn |